{"nct_id":"NCT02580058","title":"A Study Of Avelumab Alone Or In Combination With Pegylated Liposomal Doxorubicin Versus Pegylated Liposomal Doxorubicin Alone In Patients With Platinum Resistant/Refractory Ovarian Cancer (JAVELIN Ovarian 200)","status":"COMPLETED","status_verified_date":"2023-06","start_date":"2015-12-21","start_date_type":"ACTUAL","primary_completion_date":"2018-09-19","primary_completion_date_type":"ACTUAL","completion_date":"2022-07-12","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["PFE"]}